17.02
전일 마감가:
$17.36
열려 있는:
$17.36
하루 거래량:
359.34K
Relative Volume:
0.22
시가총액:
$2.20B
수익:
$2.89B
순이익/손실:
$-33.80M
주가수익비율:
-63.02
EPS:
-0.27
순현금흐름:
$204.10M
1주 성능:
-0.29%
1개월 성능:
-22.50%
6개월 성능:
-26.54%
1년 성능:
-20.69%
Surgery Partners Inc Stock (SGRY) Company Profile
명칭
Surgery Partners Inc
전화
615-234-5900
주소
310 SEVEN SPRINGS WAY, BRENTWOOD, TN
SGRY을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
SGRY
Surgery Partners Inc
|
17.02 | 2.25B | 2.89B | -33.80M | 204.10M | -0.27 |
|
HCA
Hca Healthcare Inc
|
484.85 | 111.28B | 74.37B | 7.31B | 8.10B | 25.88 |
|
THC
Tenet Healthcare Corp
|
210.84 | 18.64B | 20.69B | 2.40B | 1.55B | 15.62 |
|
UHS
Universal Health Services Inc
|
230.06 | 14.41B | 16.08B | 1.20B | 1.06B | 17.82 |
|
FMS
Fresenius Medical Care Ag Adr
|
23.28 | 13.55B | 21.23B | 924.30M | 2.22B | 1.2272 |
|
EHC
Encompass Health Corp
|
112.24 | 11.37B | 5.51B | 494.70M | 386.40M | 4.84 |
Surgery Partners Inc Stock (SGRY) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-18 | 재개 | JP Morgan | Neutral |
| 2025-07-28 | 재개 | BofA Securities | Buy |
| 2024-12-16 | 개시 | BofA Securities | Buy |
| 2024-10-14 | 개시 | UBS | Buy |
| 2024-10-11 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2024-06-28 | 개시 | Macquarie | Outperform |
| 2024-03-06 | 개시 | Barclays | Equal Weight |
| 2023-11-14 | 업그레이드 | TD Cowen | Market Perform → Outperform |
| 2023-06-02 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2023-05-12 | 개시 | Mizuho | Buy |
| 2023-04-21 | 개시 | Cantor Fitzgerald | Overweight |
| 2022-11-23 | 재확인 | RBC Capital Mkts | Outperform |
| 2022-06-15 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2022-01-10 | 재개 | Citigroup | Buy |
| 2021-11-30 | 개시 | Barclays | Overweight |
| 2021-11-29 | 업그레이드 | Stifel | Hold → Buy |
| 2021-11-01 | 개시 | JP Morgan | Neutral |
| 2021-10-18 | 개시 | SVB Leerink | Outperform |
| 2021-09-10 | 개시 | Cowen | Market Perform |
| 2021-06-23 | 재개 | Stifel | Hold |
| 2020-09-17 | 재확인 | The Benchmark Company | Buy |
| 2020-04-27 | 업그레이드 | The Benchmark Company | Hold → Buy |
| 2020-03-03 | 다운그레이드 | The Benchmark Company | Buy → Hold |
| 2020-01-14 | 재확인 | The Benchmark Company | Buy |
| 2018-11-16 | 개시 | UBS | Neutral |
| 2018-09-18 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2018-06-28 | 업그레이드 | Stifel | Sell → Hold |
| 2018-01-30 | 재확인 | The Benchmark Company | Buy |
| 2017-11-01 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2017-08-09 | 다운그레이드 | KeyBanc Capital Mkts | Overweight → Sector Weight |
| 2017-08-09 | 다운그레이드 | Raymond James | Strong Buy → Mkt Perform |
| 2017-08-09 | 다운그레이드 | Stifel | Hold → Sell |
| 2017-04-24 | 재확인 | Stifel | Hold |
| 2017-03-10 | 다운그레이드 | Stifel | Buy → Hold |
| 2017-01-31 | 개시 | The Benchmark Company | Buy |
| 2016-06-10 | 개시 | KeyBanc Capital Mkts | Overweight |
| 2016-03-14 | 재확인 | RBC Capital Mkts | Outperform |
| 2015-10-27 | 개시 | Stifel | Buy |
| 2015-10-26 | 개시 | RBC Capital Mkts | Outperform |
| 2015-10-26 | 개시 | Raymond James | Strong Buy |
모두보기
Surgery Partners Inc 주식(SGRY)의 최신 뉴스
What dividend safety score for Surgery Partners Inc. stockEarnings Overview Report & Comprehensive Market Scan Insights - Newser
Why analysts remain bullish on Surgery Partners Inc. stockBull Run & Weekly Top Gainers Trade List - Newser
Published on: 2025-12-05 01:43:55 - Newser
Surgery Partners, Inc. (SGRY) Under Investigation for Potential Securities Law ViolationsContact Levi & Korsinsky Today - ACCESS Newswire
How Surgery Partners Inc. stock reacts to global recession fears2025 Volume Leaders & Free High Return Stock Watch Alerts - Newser
XTX Topco Ltd Acquires 70,391 Shares of Surgery Partners, Inc. $SGRY - MarketBeat
Surgery Partners, Inc. (NASDAQ:SGRY) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Can Surgery Partners Inc. stock maintain growth trajectory2025 Analyst Calls & Free Daily Entry Point Trade Alerts - moha.gov.vn
Surgery Partners' takeover offer should rekindle interestanalyst - MSN
History Review: How supply chain issues affect Surgery Partners Inc. stockJuly 2025 Analyst Calls & Long-Term Capital Growth Ideas - moha.gov.vn
Bronstein, Gewirtz & Grossman, LLC Is Investigating Surgery Partners, Inc. (SGRY) And Encourages Shareholders to Connect - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Surgery Partners, Inc. (SGRY) And Encourages Shareholders to Reach Out - ACCESS Newswire
Assessing Surgery Partners (SGRY) Valuation Following Fed-Driven Investor Optimism and Recent Share Price Rebound - Yahoo Finance
Alignment Healthcare, Hims & Hers Health, Surgery Partners, Guardant Health, and Pediatrix Medical Group Stocks Trade Up, What You Need To Know - Finviz
JP Morgan Lowers Surgery Partners (SGRY) Price Target to $20 | S - GuruFocus
Surgery Partners, Inc. (SGRY) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Barclays Keeps Their Hold Rating on Surgery Partners (SGRY) - The Globe and Mail
Zoetis and Surgery Partners Shares Are Soaring, What You Need To Know - The Globe and Mail
SGRY Analyst Rating Update: Barclays Lowers Price Target to $18. - GuruFocus
Surgery Partners, Inc. (SGRY) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Surgery Partners (SGRY): Assessing Valuation After Recent 27% Share Price Drop - Sahm
Why Surgery Partners Inc. stock is favored by pension fundsProfit Target & Fast Exit/Entry Strategy Plans - newser.com
Bronstein, Gewirtz & Grossman, LLC Is Investigating Surgery Partners, Inc. (SGRY) And Encourages Stockholders to Connect - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Is Investigating Surgery Partners, Inc. (SGRY) And Encourages Investors to Connect - ACCESS Newswire
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Surgery Partners, Inc.SGRY - MarketScreener
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Surgery Partners, Inc.SGRY - cnhinews.com
Surgery Partners price target lowered to $22 from $28 at Mizuho - MSN
Is Surgery Partners Inc. stock recession proofJuly 2025 Short Interest & Low Risk Growth Stock Ideas - newser.com
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Surgery Partners, Inc. (SGRY) And Encourages Stockholders to Reach Out - ACCESS Newswire
Can Surgery Partners Inc. stock sustain market leadershipQuarterly Growth Report & Verified Trade Idea Suggestions - newser.com
Bronstein, Gewirtz & Grossman, LLC Encourages Surgery Partners, Inc. (SGRY) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
What data driven models say about Surgery Partners Inc.’s futureMarket Activity Report & Low Risk Growth Stock Ideas - newser.com
3 Reasons to Sell SGRY and 1 Stock to Buy Instead - Yahoo Finance
Automated trading signals detected on Surgery Partners Inc.Portfolio Growth Summary & Weekly Sector Rotation Insights - newser.com
Surgery Partners Inc. stock momentum explained2025 Market Trends & Safe Swing Trade Setups - newser.com
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Surgery Partners, Inc. (SGRY) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
AirSculpt Technologies Appoints Mike Doyle as Non-Executive Chairman of the Board - GlobeNewswire Inc.
Mizuho lowers Surgery Partners stock price target on payer mix concerns - Investing.com Canada
Surgery Partners stock hits 52-week low at $15.09 - Investing.com
Surgery Partners stock hits 52-week low at $15.09 By Investing.com - Investing.com South Africa
Mizuho Lowers Price Target for Surgery Partners (SGRY) While Mai - GuruFocus
Surgery Partners: Surgery Partners, Inc.Flex Position Consolidation Option Symbol: 1SGRY - 富途牛牛
Developing predictive dashboards with Surgery Partners Inc. dataPortfolio Update Summary & Daily Stock Momentum Reports - newser.com
Using RSI to spot recovery in Surgery Partners Inc.Earnings Trend Report & Precise Trade Entry Recommendations - newser.com
Surgery Partners Inc (SGRY) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):